Interestingly, our findings indicated and confirmed that the hyper methylated pattern of PTPRG gene in CML patients acts as an early promoter for CML formation and to be dependent on BCR‐ABL1 titers. The gene discussed is PTPRG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.